620 related articles for article (PubMed ID: 26223157)
1. Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial.
Quarello P; Fagioli F; Basso G; Putti MC; Berger M; Luciani M; Rizzari C; Menna G; Masetti R; Locatelli F
Br J Haematol; 2015 Nov; 171(4):566-73. PubMed ID: 26223157
[TBL] [Abstract][Full Text] [Related]
2. Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia.
Pession A; Masetti R; Rizzari C; Putti MC; Casale F; Fagioli F; Luciani M; Lo Nigro L; Menna G; Micalizzi C; Santoro N; Testi AM; Zecca M; Biondi A; Pigazzi M; Rutella S; Rondelli R; Basso G; Locatelli F;
Blood; 2013 Jul; 122(2):170-8. PubMed ID: 23673857
[TBL] [Abstract][Full Text] [Related]
3. Outcome of myeloablative allogeneic peripheral blood hematopoietic stem cell transplantation for refractory/relapsed AML patients in NR status.
Liu N; Ning HM; Hu LD; Jiang M; Xu C; Hu JW; Wang J; Li YH; Li BT; Lou X; Yang F; Chen JL; Su YF; Li M; Wang HY; Ren J; Feng YQ; Zhang B; Wang DH; Chen H
Leuk Res; 2015 Dec; 39(12):1375-81. PubMed ID: 26530539
[TBL] [Abstract][Full Text] [Related]
4. Comparison of a fludarabine and melphalan combination-based reduced toxicity conditioning with myeloablative conditioning by radiation and/or busulfan in acute myeloid leukemia in Japanese children and adolescents.
Ishida H; Adachi S; Hasegawa D; Okamoto Y; Goto H; Inagaki J; Inoue M; Koh K; Yabe H; Kawa K; Kato K; Atsuta Y; Kudo K
Pediatr Blood Cancer; 2015 May; 62(5):883-9. PubMed ID: 25545836
[TBL] [Abstract][Full Text] [Related]
5. Treatment of children with acute myeloid leukaemia who relapsed after allogeneic haematopoietic stem cell transplantation.
Lee JW; Jang PS; Chung NG; Cho B; Kim HK
Br J Haematol; 2013 Jan; 160(1):80-6. PubMed ID: 23106148
[TBL] [Abstract][Full Text] [Related]
6. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group.
Amadori S; Testi AM; Aricò M; Comelli A; Giuliano M; Madon E; Masera G; Rondelli R; Zanesco L; Mandelli F
J Clin Oncol; 1993 Jun; 11(6):1046-54. PubMed ID: 8501490
[TBL] [Abstract][Full Text] [Related]
7. Sequential chemotherapy followed by reduced-intensity conditioning and allogeneic haematopoietic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukaemia: a survey from the Acute Leukaemia Working Party of EBMT.
Ringdén O; Labopin M; Schmid C; Sadeghi B; Polge E; Tischer J; Ganser A; Michallet M; Kanz L; Schwerdtfeger R; Nagler A; Mohty M;
Br J Haematol; 2017 Feb; 176(3):431-439. PubMed ID: 27879990
[TBL] [Abstract][Full Text] [Related]
8. Effects of priming with recombinant human granulocyte colony-stimulating factor on conditioning regimen for high-risk acute myeloid leukemia patients undergoing human leukocyte antigen-haploidentical hematopoietic stem cell transplantation: a multicenter randomized controlled study in southwest China.
Gao L; Wen Q; Chen X; Liu Y; Zhang C; Gao L; Kong P; Zhang Y; Li Y; Liu J; Wang Q; Su Y; Wang C; Wang S; Zeng Y; Sun A; Du X; Zeng D; Liu H; Peng X; Zhang X
Biol Blood Marrow Transplant; 2014 Dec; 20(12):1932-9. PubMed ID: 25109850
[TBL] [Abstract][Full Text] [Related]
9. Survival after second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia.
Meshinchi S; Leisenring WM; Carpenter PA; Woolfrey AE; Sievers EL; Radich JP; Sanders JE
Biol Blood Marrow Transplant; 2003 Nov; 9(11):706-13. PubMed ID: 14652854
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic bone marrow transplantation in children with acute myelogenous leukemia in first remission. Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO).
Dini G; Boni L; Abla O; Uderzo C; Polchi P; Locatelli F; Di Bartolomeo P; Arcese W; Iori AP; Rossetti F
Bone Marrow Transplant; 1994 Jun; 13(6):771-6. PubMed ID: 7920313
[TBL] [Abstract][Full Text] [Related]
11. Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial.
Röllig C; Serve H; Hüttmann A; Noppeney R; Müller-Tidow C; Krug U; Baldus CD; Brandts CH; Kunzmann V; Einsele H; Krämer A; Schäfer-Eckart K; Neubauer A; Burchert A; Giagounidis A; Krause SW; Mackensen A; Aulitzky W; Herbst R; Hänel M; Kiani A; Frickhofen N; Kullmer J; Kaiser U; Link H; Geer T; Reichle A; Junghanß C; Repp R; Heits F; Dürk H; Hase J; Klut IM; Illmer T; Bornhäuser M; Schaich M; Parmentier S; Görner M; Thiede C; von Bonin M; Schetelig J; Kramer M; Berdel WE; Ehninger G;
Lancet Oncol; 2015 Dec; 16(16):1691-9. PubMed ID: 26549589
[TBL] [Abstract][Full Text] [Related]
12. Favorable outcomes after allogeneic hematopoietic stem cell transplantation in children with high-risk or advanced acute myeloid leukemia.
Koh KN; Park M; Kim BE; Bae KW; Im HJ; Seo JJ
J Pediatr Hematol Oncol; 2011 May; 33(4):281-8. PubMed ID: 21464766
[TBL] [Abstract][Full Text] [Related]
13. Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the aieop AML-2002/01 study.
Locatelli F; Masetti R; Rondelli R; Zecca M; Fagioli F; Rovelli A; Messina C; Lanino E; Bertaina A; Favre C; Giorgiani G; Ripaldi M; Ziino O; Palumbo G; Pillon M; Pession A; Rutella S; Prete A
Bone Marrow Transplant; 2015 Feb; 50(2):181-8. PubMed ID: 25387094
[TBL] [Abstract][Full Text] [Related]
14. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of children with high-risk acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation following complete remission with initial induction chemotherapy in the AML-05 clinical trial.
Hyakuna N; Hashii Y; Ishida H; Umeda K; Takahashi Y; Nagasawa M; Yabe H; Nakazawa Y; Koh K; Goto H; Fujisaki H; Matsumoto K; Kakuda H; Yano M; Tawa A; Tomizawa D; Taga T; Adachi S; Kato K
Pediatr Blood Cancer; 2019 Oct; 66(10):e27875. PubMed ID: 31309713
[TBL] [Abstract][Full Text] [Related]
16. Non-TBI hematopoietic stem cell transplantation in pediatric AML patients: a single-center experience.
Hamidieh AA; Alimoghaddam K; Jahani M; Bahar B; Mousavi SA; Iravani M; Behfar M; Jalali A; Jalili M; Hamdi A; Ghavamzadeh A
J Pediatr Hematol Oncol; 2013 Aug; 35(6):e239-45. PubMed ID: 23042019
[TBL] [Abstract][Full Text] [Related]
17. Outcome in 146 patients with paediatric acute myeloid leukaemia treated according to the AML99 protocol in the period 2003-06 from the Japan Association of Childhood Leukaemia Study.
Imamura T; Iwamoto S; Kanai R; Shimada A; Terui K; Osugi Y; Kobayashi R; Tawa A; Kosaka Y; Kato K; Hori H; Horibe K; Oda M; Adachi S;
Br J Haematol; 2012 Oct; 159(2):204-10. PubMed ID: 22924344
[TBL] [Abstract][Full Text] [Related]
18. Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocols.
Pession A; Rondelli R; Basso G; Rizzari C; Testi AM; Fagioli F; De Stefano P; Locatelli F;
Leukemia; 2005 Dec; 19(12):2043-53. PubMed ID: 16107897
[TBL] [Abstract][Full Text] [Related]
19. Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia.
Damiani D; Tiribelli M; Geromin A; Cerno M; Sperotto A; Toffoletti E; Simeone E; Michelutti A; Cavallin M; Fanin R
Ann Hematol; 2012 Dec; 91(12):1937-43. PubMed ID: 22893485
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cladribine- and fludarabine-based induction chemotherapy in relapsed or refractory acute myeloid leukaemia.
Park H; Youk J; Kim I; Yoon SS; Park S; Lee JO; Bang SM; Koh Y
Ann Hematol; 2016 Oct; 95(11):1777-86. PubMed ID: 27539617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
